Information Provided By:
Fly News Breaks for November 8, 2019
Nov 8, 2019 | 05:51 EDT
Piper Jaffray analyst Sean Wieland lowered his price target for Tabula Rasa HealthCare to $66 from $78 saying the company posted a "squishy quarter" and guided Q4 below Street views on the downsizing of a significant client. However, the contract loss "is not a canary in the coal mine," as it was a non-recurring telephonic services engagement, and the client's strategy abruptly pivoted in the midst of a large merger, Wieland tells investors in a research note. He reiterates an Overweight rating on Tabula Rasa HealthCare.
News For TRHC From the Last 2 Days
There are no results for your query TRHC